AR040001A1 - Formulaciones de bisfosfonatos de uso inyectable - Google Patents

Formulaciones de bisfosfonatos de uso inyectable

Info

Publication number
AR040001A1
AR040001A1 ARP030101639A ARP030101639A AR040001A1 AR 040001 A1 AR040001 A1 AR 040001A1 AR P030101639 A ARP030101639 A AR P030101639A AR P030101639 A ARP030101639 A AR P030101639A AR 040001 A1 AR040001 A1 AR 040001A1
Authority
AR
Argentina
Prior art keywords
injectable use
bisphosphonate formulations
range
use bisphosphonate
formulations
Prior art date
Application number
ARP030101639A
Other languages
English (en)
Inventor
Andrea Capocchi
Rossella Musa
Raschini Annamaria Soliani
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27639074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR040001(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of AR040001A1 publication Critical patent/AR040001A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composición farmacéutica en forma de solución acuosa, con un valor de pH en el intervalo de 3,5 a 5,5, que contiene una sal alcalina de un ácido bisfosfónico y clorhidrato de lidocaína, en una concentración en el intervalo de 0,5 y 2,0% (p / v). Dicha composición es particularmente apropiada para la administración por vía intramuscular.
ARP030101639A 2002-05-13 2003-05-12 Formulaciones de bisfosfonatos de uso inyectable AR040001A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002TO000406A ITTO20020406A1 (it) 2002-05-13 2002-05-13 Formulazioni di bisfosfonati ad uso iniettabile.

Publications (1)

Publication Number Publication Date
AR040001A1 true AR040001A1 (es) 2005-03-09

Family

ID=27639074

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101639A AR040001A1 (es) 2002-05-13 2003-05-12 Formulaciones de bisfosfonatos de uso inyectable

Country Status (5)

Country Link
AR (1) AR040001A1 (es)
AU (1) AU2003240225A1 (es)
IT (1) ITTO20020406A1 (es)
PE (1) PE20040193A1 (es)
WO (1) WO2003094925A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012700A1 (en) * 2004-08-04 2006-02-09 Team Health Pty Ltd Method of treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
IT1296495B1 (it) * 1997-11-21 1999-06-25 Prodotti Antibiotici Spa Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare
US6677320B2 (en) * 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
EP1136069A1 (en) * 2000-03-21 2001-09-26 SPA SOCIETA' PRODOTTI ANTIBIOTICI S.p.A. Pharmaceutical compositions containing clodronates for high local tolerance intramuscular administration

Also Published As

Publication number Publication date
ITTO20020406A1 (it) 2003-11-13
AU2003240225A1 (en) 2003-11-11
PE20040193A1 (es) 2004-05-31
ITTO20020406A0 (it) 2002-05-13
WO2003094925A1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
AR043863A1 (es) Composiciones que contienen piperacilina y tazobactam, utiles para inyeccioines
PE20020127A1 (es) Interleuquina 2 estabilizada
AR098830A2 (es) Suspensiones acuosas estabilizadas para administración parenteral
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
CR6106A (es) Desnaturalizantes para sales aminas simpaticomimeticas
CL2010000816A1 (es) Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06)
PE20140960A1 (es) Formulaciones que comprenden un inhibidor de dpp4
UY26496A1 (es) Composiciones farmacéuticas que proporcionan concentraciones potenciadas de fármaco
AR037789A1 (es) Soluciones de meloxicam estables y muy concentradas para la inyeccion sin aguja
CU23367A3 (es) Formulación de moxifloxacino con sal común
PE20080741A1 (es) Formulaciones parenterales de metilnaltrexona y sus sales
MEP39808A (en) Highly concentrated stable meloxicam solutions
BRPI0513673A (pt) método para aumentar a eficácia e o transporte dos compostos biologicamente ativos enteralmente administrados, veìculo utilizado na administração enteral de compostos biologicamente ativos, composição farmacêutica e uso de uma quantidade eficaz de um ou mais derivados de fosfato
MY151470A (en) Controlled release solid preparation
CO6290629A2 (es) Composiciones de limpieza de amino ácido básico y métodos
PT1589949E (pt) Composições liofilizadas estabilizadas compreendendo inibidor da coagulação por factores tecidulares ou variante de inibidor da coagulação por factores tecidulares
BRPI0111911B8 (pt) preparado aplicável por via oral compreendendo ciprofloxacina
AR070593A1 (es) Composiciones efervescentes
BR0315513A (pt) Composição farmacêutica injetável, processo para preparação de composição farmacêutica, e, uso de cefquinoma em um veìculo com liberação prolongada
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
DE60232271D1 (de) Wässrige pharmazeutische formulierungen von wasserlöslichen prodrugs von propofol-verbindungen
AR038985A1 (es) Parecoxib sodico cristalino
AR040001A1 (es) Formulaciones de bisfosfonatos de uso inyectable
AR010178A1 (es) Preparados farmaceuticos que contienen como principio activo cilansetron, empleo de aditivos y procedimiento para la produccion de dichos preparados
CO5550418A2 (es) Formulaciones antihistaminicas para formas de dosificacion de capsula blanda

Legal Events

Date Code Title Description
FB Suspension of granting procedure